Cyclothiocarbamate derivatives as progesterone receptor modulators
US8466146B2 · kind B2 · utility
2Cited by
85References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2012 |
| Grant date | Jun 18, 2013 |
| Priority date | — |
| Expiry date | Nov 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure:wherein R1, R2, R3, R4, R5, and Q1 are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.